Medical Journals

Aspirin-triggered Lipoxins Override the Apoptosis-delaying Action of Serum Amyloid A in Human Neutrophils: a Novel Mechanism for Resolution of Inflammation.

Authors:
  • El Kebir Driss
  • József Levente
  • Khreiss Tarek
  • Pan Wanling
  • Petasis Nicos A
  • Serhan Charles N
  • Filep János G

From: Research Center, Maisonneuve-Rosemont Hospital and Department of Pathology and Cell Biology, University of Montréal, 5415 Boulevard de l’Assomption, Montréal, Quebec, Canada.

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Jul 2007
  • ISSN: 0022-1767
  • Volume: 179
  • Issue: 1
  • Pages: 616-22
  • Medium: Print
  • Language: English
  • Citation (JAMA): El Kebir Driss, József Levente, Khreiss Tarek, et al. Aspirin-triggered Lipoxins Override the Apoptosis-delaying Action of Serum Amyloid A in Human Neutrophils: a Novel Mechanism for Resolution of Inflammation.. J. Immunol. Jul 2007;179:616-22

Abstract

Elevated plasma levels of the acute-phase reactant serum amyloid A (SAA) have been used as a marker and predictor of inflammatory diseases. SAA regulates leukocyte activation; however, it is not known whether it also modulates neutrophil apoptosis, which is critical to the optimal expression and resolution of inflammation. Culture of human neutrophils with SAA (0.1-20 microg/ml) markedly prolonged neutrophil longevity by delaying constitutive apoptosis. SAA evoked concurrent activation of the ERK and PI3K/Akt signaling pathways, leading to phosphorylation of BAD at Ser(112) and Ser(136), respectively, and to prevention of collapse of mitochondrial transmembrane potential, cytochrome c release, and caspase-3 activation. These actions were abrogated by pharmacological inhibition of the formyl peptide receptor, ERK or PI3K. Furthermore, aspirin-triggered 15-epi-lipoxin A(4) (15-epi-LXA(4)) and its stable analog 15-epi-16-p-fluorophenoxy-LXA(4), which binds to the same receptor as SAA, effectively overrode the antiapoptosis signal from SAA even when neutrophils were treated with 15-epi-LXA(4) at either 1 or 4 h postculture with SAA. 15-Epi-LXA(4) itself did not affect neutrophil survival and apoptosis. Our results indicate that SAA at clinically relevant concentrations promotes neutrophil survival by suppressing the apoptotic machinery, an effect that can be opposed by 15-epi-LXA(4). The opposing actions of SAA and aspirin-triggered 15-epi-LXA(4) may contribute to the local regulation of exacerbation and resolution of inflammation, respectively.

Mesh Headings (Keywords): Apoptosis, Apoptosis Regulatory Proteins, Aspirin, Cell Survival, Cells, Cultured, Humans, Inflammation Mediators, Lipoxins, Membrane Potential, Mitochondrial, Neutrophils, Receptors, Lipoxin, Serum Amyloid A Protein, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17579083


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.